Publication | Closed Access

An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study

Elderly PatientsGfpc 02-02B StudyMedicineAdvanced Lung DiseaseClinical TrialsWeekly DocetaxelCancer TreatmentOncologyRadiation OncologyLung CancerHealth Sciences